These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8694104)

  • 1. Treatment of persistent glaucoma secondary to periocular corticosteroids.
    Akduman L; Kolker AE; Black DL; Del Priore LV; Kaplan HJ
    Am J Ophthalmol; 1996 Aug; 122(2):275-7. PubMed ID: 8694104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intraocular pressure elevation after subtenon injection of triamcinolone acetonide during uveitis].
    Bui Quoc E; Bodaghi B; Adam R; Burtin T; Cassoux N; Dreifuss S; Fardeau C; LeHoang P
    J Fr Ophtalmol; 2002 Dec; 25(10):1048-56. PubMed ID: 12527830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periocular triamcinolone acetonide injections for cystoid macular edema complicating noninfectious uveitis.
    Leder HA; Jabs DA; Galor A; Dunn JP; Thorne JE
    Am J Ophthalmol; 2011 Sep; 152(3):441-448.e2. PubMed ID: 21652023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
    Sallam A; Sheth HG; Habot-Wilner Z; Lightman S
    Am J Ophthalmol; 2009 Aug; 148(2):207-213.e1. PubMed ID: 19403113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
    Nazm N; Dubey S; Gandhi M; Pegu J
    Am J Ophthalmol; 2010 Mar; 149(3):525-6; author reply 526-7. PubMed ID: 20172078
    [No Abstract]   [Full Text] [Related]  

  • 6. [Safety and efficacy of subconjunctival triamcinolone injections in the management of uveitic macular edema: retrospective study of thirty-one cases].
    Bleriot A; Couret C; Le Meur G; Lebranchu P; Weber M
    J Fr Ophtalmol; 2014 Oct; 37(8):599-604. PubMed ID: 25199486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis.
    Helm CJ; Holland GN
    Am J Ophthalmol; 1995 Jul; 120(1):55-64. PubMed ID: 7611330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical quantification of triamcinolone in subconjunctival depots.
    Kalina PH; Erie JC; Rosenbaum L
    Arch Ophthalmol; 1995 Jul; 113(7):867-9. PubMed ID: 7605276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periocular corticosteroid injections in uveitis: effects and complications.
    Sen HN; Vitale S; Gangaputra SS; Nussenblatt RB; Liesegang TL; Levy-Clarke GA; Rosenbaum JT; Suhler EB; Thorne JE; Foster CS; Jabs DA; Kempen JH
    Ophthalmology; 2014 Nov; 121(11):2275-86. PubMed ID: 25017415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of intravitreal steroid injections.
    Reichle ML
    Optometry; 2005 Aug; 76(8):450-60. PubMed ID: 16150412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe intraocular pressure response to periocular or intravitreal steroid treatment in Australia and New Zealand: data from the Australian and New Zealand Ophthalmic Surveillance Unit.
    Fitzgerald JT; Saunders L; Ridge B; White AJ; Goldberg I; Clark B; Mills RA; Craig JE
    Clin Exp Ophthalmol; 2015 Apr; 43(3):234-8. PubMed ID: 25214011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory severe ocular hypertension after intravitreal triamcinolone acetonide injection.
    Yang CS; Chen MJ; Chou CK; Hsu WM
    Ophthalmologica; 2005; 219(6):413-5. PubMed ID: 16286805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of persistent glaucoma secondary to depot methylprednisolone.
    Aydin A; Akin T; Bilge AH
    Ophthalmic Surg Lasers Imaging; 2007; 38(5):399-401. PubMed ID: 17955845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraocular pressure after intravitreal injection of triamcinolone acetonide.
    Jonas JB; Kreissig I; Degenring R
    Br J Ophthalmol; 2003 Jan; 87(1):24-7. PubMed ID: 12488256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Jonas JB; Degenring RF; Kreissig I; Akkoyun I; Kamppeter BA
    Ophthalmology; 2005 Apr; 112(4):593-8. PubMed ID: 15808249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraocular Pressure after Intravitreal Triesence Injection.
    Atchison EA; Bakri SJ
    Semin Ophthalmol; 2018; 33(3):308-312. PubMed ID: 27935332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
    Jonas JB; Kreissig I; Kamppeter B; Degenring RF
    Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late intraocular pressure rise following intravitreal triamcinolone injection.
    Williams CP; Konstantopoulos A; Rowley SA; Luff AJ
    Clin Exp Ophthalmol; 2007; 35(4):385-6. PubMed ID: 17539797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New drugs in the treatment of noninfectious uveitis].
    Cano-Parra J; Díaz-Llopis M
    Arch Soc Esp Oftalmol; 2006 Dec; 81(12):671-3. PubMed ID: 17199159
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of intravitreal triamcinolone acetonide on intraocular pressure.
    Bakri SJ; Beer PM
    Ophthalmic Surg Lasers Imaging; 2003; 34(5):386-90. PubMed ID: 14509462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.